Healthtech Startups

Atrys Health is a medical company specializing in oncology, telediagnosis, pathological anatomy, and nuclear medicine. It operates in the healthcare and diagnostics sector.

2 investors

Atterx develops novel pharmaceutical therapies to prevent and treat antibiotic-resistant bacterial infections using bacterial interference and conjugation technologies. The company targets multi-drug resistant infections through specialty pharmaceutical products designed for clinical development.

2 investors

Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.

2 investors

Attuned Intelligence builds an AI Voice Agent that answers and routes patient phone calls 24/7 for healthcare providers such as community health centers and hospital systems. The system offers multilingual answering, real-time AI plus human supervision, EHR integration (e.g. Epic) for scheduling and refills, and analytics on call intents and outcomes.

2 investors

Audacious Inquiry provides advisory services, software, and information services for healthcare interoperability and health data exchange, serving federal agencies, state governments, public health departments, hospitals, and payer organizations. A wholly-owned subsidiary of PointClickCare, it supports care collaboration across long-term care providers, ambulatory clinics, and government agencies in the United States.

2 investors

Augment Therapy builds movement and rehabilitation software that uses its patented MOCAST computer vision platform and game-based ARWell products to make physical therapy and wellness activities engaging for children, people with disabilities, and older adults. The company serves therapists, patients, and clinical programs across multiple care settings.

2 investors

Augmental develops body-coupled interfaces that enable hands-free control of computers and communication with AI, designed primarily for people with severe motor limitations. The company's products, MouthPad and VOX, provide cursor control and voice input respectively for individuals unable to use their hands.

2 investors

Aurealis Therapeutics is a Swiss-Finnish clinical-stage company developing multi-target bacterial gene therapies based on genetically engineered Lactococcus cremoris, using a modular platform that produces multiple human therapeutic proteins directly in diseased tissue. Its therapies target chronic wounds, cancer, and inflammatory diseases, with a lead product for diabetic foot ulcers.

2 investors

Aurenar develops a non-invasive, ear-worn neuromodulation wearable that stimulates a nerve in the ear to boost the body's natural control of inflammation, targeting complications in intensive care unit patients. The device aims to improve patient outcomes, reduce hospital length of stay, and lower the cost of ICU care.

2 investors

Auricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.

2 investors

Aurie designs a reusable intermittent catheter system intended to reduce infection risk and improve ease of use compared with single-use catheters. The company develops catheter and ostomy products in partnership with the disabled community to support health, independence, and daily living.

2 investors

The page profiles a scientific advisor in surgical endoscopy and flexible robotics, indicating the company operates in medical technology related to interventional endoscopy and minimally invasive surgery. It provides no direct description of the company's own products or offerings.

2 investors

耀乘健康科技 (AuroraPrime) is an AI platform for the life sciences and pharmaceutical industry that automates the generation of regulatory and medical documents such as clinical study reports, protocols, and safety narratives across the R&D lifecycle. It also offers Intelligent EDC and medical monitoring tools for pharmaceutical companies, CROs, and research organizations.

2 investors

AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV). It uses a proprietary Med-Oligo ASO platform and targeted delivery technologies to address viral infections, metabolic, genetic, and immune diseases.

2 investors

Author Health provides mental health and behavioral care for patients covered by Medicare, Medicare-Medicaid dual-eligible plans, and Medicare Advantage/Special Needs Plans, including the GUIDE program. It serves patients in Arizona, Florida, Illinois, Indiana, New Jersey, Pennsylvania, and Texas.

2 investors

Autifony Therapeutics is a privately funded biopharmaceutical company developing treatments for neurological conditions including Fragile X Syndrome and orphan epilepsy syndromes.

2 investors

Automate Clinic is a multi-specialty medical group offering specialized, insurance-accepted care delivered remotely from patients' homes with continuity from a dedicated doctor. The service is described as coming soon.

2 investors

AutonomUS develops technology to automate and standardize image-guided interventional medical procedures, aiming to make specialist interventional expertise available across settings from ERs and outpatient clinics to operating rooms and battlefield care. The company originated from a Department of Defense–supported collaboration between Massachusetts General Hospital physicians and MIT Lincoln Laboratory scientists.

2 investors

AutoPhagyGO is a biotech company focused on autophagy research with applications in longevity and age-related disease prevention and treatment. The company leverages cellular regeneration mechanisms to develop therapeutics that promote healthy aging.

2 investors

AI agents that automate documentation workflows for skilled nursing facilities, including nursing notes, MDS assessments, progress notes, and weekly assessments with compliance and PDPM validation.

2 investors

Auxa provides care coordination software that uses AI and real-time data to standardize clinical tasks, navigate insurance coverage and resources, manage medications, and facilitate provider referrals for healthcare organizations. The platform serves inpatient, outpatient, home-based care teams, pharmacies, and member services within at-risk healthcare systems.

2 investors

Auxira Health operates in the healthcare sector, providing clinical services to patients through remote and clinic-based models. The company emphasizes patient-centered care and employs medical professionals including physicians and medical assistants.

2 investors

Revenue cycle management platform and electronic clearinghouse

2 investors

Avails Medical develops the eQUANT™ System, an FDA-cleared diagnostic platform using electronic biosensor technology for rapid antimicrobial susceptibility testing in infectious disease care. The system targets hospitals and clinical laboratories to accelerate diagnosis of infections like sepsis and combat antimicrobial resistance.

2 investors